𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Removing patients from the liver transplant wait list: A survey of US liver transplant programs

✍ Scribed by Kevin P. Charpentier; Arun Mavanur


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
383 KB
Volume
14
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Guidelines are in place regarding who is a candidate for liver transplantation. Once a potential candidate is listed, there are no uniform guidelines indicating when he should be removed from the list because of a change in clinical status. A survey with 14 scenarios was sent to the medical and surgical directors of all liver transplant programs in the United States. In each scenario, clinical information was provided about a patient active on the transplant wait list. Data regarding a clinical change were provided, and responders were questioned whether they would remove the patient from the wait list. The scenarios were designed to address the issues of age, etiology of liver disease, renal dysfunction, respiratory failure, infection, failure to thrive, and social support. Two hundred four questionnaires were mailed with 47 responses (23%): 8 return to sender, 24 surgeons, and 15 hepatologists. All 11 United Network for Organ Sharing regions were represented. The responders were well distributed among university programs (n = 28), private practice programs (n = 10), and health maintenance organization programs (n = 1). Nine responses were from small-volume programs (< or =25 transplants), 12 were from medium-volume programs (26-50 transplants), and 18 were from large-volume programs (> or =51 transplants). There was wide variability between responders regarding which patients should be removed from the transplant wait list. Patient age and etiology of liver disease led to the greatest discordance among responders. In conclusion, there is a lack of agreement and standardization among US liver transplant programs regarding who should be removed from the wait list for a change in clinical status.


πŸ“œ SIMILAR VOLUMES


Alcohol use while on the liver transplan
✍ Michelle Carbonneau; Louise A. Jensen; Vincent G. Bain; Karen Kelly; Glenda Meeb πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

Alcoholic liver disease (ALD) is a leading indication for liver transplantation. Our center has randomly checked blood alcohol levels (BALs) in ALD patients on the waiting list since 2004. We aimed to identify the incidence and predictors of inactivation on the transplant list due to alcohol use and

The potential impact of using donations
✍ Eleazar Chaib; Eduardo Massad πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 1 views

Liver transplantation was first performed at the University of Sao Paulo School of Medicine in 1968. Since then, the patient waiting list for liver transplantation has increased at a rate of 150 new cases per month. Liver transplantation itself rose 1.84-fold (from 160 to 295) from 1988 to 2004. How

Risk factors for long-term mortality in
✍ Samanta T. Basto; Cristiane A. Villela-Nogueira; Bernardo R. Tura; Henrique Serg πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

Liver donor shortage and long waiting times are observed in many liver transplant programs worldwide. The aim of this study was to evaluate the wait list in a developing country, before and after the introduction of the MELD scoring system. In addition, the MELD score ability to predict mortality in

Ablation therapy in containing extension
✍ Noriyo Yamashiki; Ryosuke Tateishi; Haruhiko Yoshida; Shuichiro Shiina; Takuma T πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 1 views

The dropout from the waiting list for liver transplantation among patients with hepatocellular carcinoma (HCC) is reportedly as high as 12% to 40% per year, mostly due to tumor progression. Considering the scarcity of donor organs, it would be beneficial if we could retain them within the Milan crit

Expanded criteria for liver transplantat
✍ Nicholas Onaca; Gary L. Davis; Robert M. Goldstein; Linda W. Jennings; GΓΆran B. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 344 KB πŸ‘ 2 views

Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging